Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -421.82M | -34.29% | $ 1.23B |
3/31/2025 | $ -381.15M | -44.44% | $ 857.67M |
12/31/2024 | $ -354.66M | -31.55% | $ 1.12B |
9/30/2024 | $ -363.06M | -22.28% | $ 1.63B |
6/30/2024 | $ -382.65M | -16.83% | $ 2.27B |
3/31/2024 | $ -418.08M | -17.43% | $ 2.4B |
12/31/2023 | $ -408.07M | -15.62% | $ 2.61B |
9/30/2023 | $ -407.28M | -18.22% | $ 2.24B |
6/30/2023 | $ -384.18M | -11.11% | $ 3.46B |
3/31/2023 | $ -378.63M | -9.84% | $ 3.85B |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for INTELLIA THERAPEUTICS INC is calculated as follows: FCF [ $ -43.5M ] / Market Cap [ $ 1.68B ]
(=) FCF Yield [ -2.59% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.58% |
median | 3.22% |
std | 11.38% |